Abstract
Background: Guillain-Barré Syndrome is a progressive autoimmune polyradiculoneuropathy characterized by symmetrical flaccid paralysis accompanied by areflexia, hyporeflexia or hyperreflexia on rare occasions. Worldwide, it remains the first cause of flaccid paralysis. It is usually associated with infectious disease history; however, there are various clinical variants, each with a different outcome. Prognosis is usually good, although 20% of patients could suffer a severe clinical variant of Guillain-Barré Syndrome and 5% will die despite treatment.
 Methods: This is a cross-sectional study, including the records of hospitalized patients with Guillain- Barré Syndrome at Mexicali’s General Hospital within a five-year period.
 Results: In a five-year span there were 64 patients with Guillain-Barré Syndrome, most of the patients were men (70.3%), with age ranging 1 to 76 years. A total of 8 (12.5%) patients died, from which 7 (87.5%) required mechanical ventilation during hospitalization. Immunoglobulin therapy was provided to 56 (87.5%) patients, and 6 (10.7%) of them perished due to acute kidney injury.
 Conclusion: Guillain-Barré Syndrome is a common disease among male population, with no dominating onset age, however, leaning for the young and elder. Most of the patients that were hospitalized at the General Hospital of Mexicali had a history of previous infection (gastrointestinal, respiratory, or other infectious diseases). The need for mechanical ventilation represents a higher severity index, nonetheless, this does not mean that assisted ventilation is directly associated with mortality. As for treatment, immunoglobulin is the most common choice for therapy, though some of the patients died from acute kidney injury.
Highlights
Landry-Guillain-Barré Strohl Syndrome is a progressive autoimmune polyradiculoneuropathy,[1] characterized by symmetrical flaccid paralysis with areflexia, hyporeflexia or hyperreflexia on very rare occasions.[2]
As for mechanical ventilation, 28% required it during the course of the disease, with an outcome of 87.5% deaths (p-value
This study reviewed 64 cases of patients with Guillain-Barré Syndrome (GBS) from 2014 through 2019, 70.3% were male and 30.16% were female with an obvious incline for males just like Carrillo-Pérez et al stated.[15]
Summary
Landry-Guillain-Barré Strohl Syndrome is a progressive autoimmune polyradiculoneuropathy,[1] characterized by symmetrical flaccid paralysis with areflexia, hyporeflexia or hyperreflexia on very rare occasions.[2] Worldwide, it remains the first cause of flaccid paralysis. It is usually associated with a previous infectious disease; this is not always the case. Guillain-Barré Syndrome is a progressive autoimmune polyradiculoneuropathy characterized by symmetrical flaccid paralysis accompanied by areflexia, hyporeflexia or hyperreflexia on rare occasions Worldwide, it remains the first cause of flaccid paralysis. As for treatment, immunoglobulin is the most common choice for therapy, though some of the patients died from acute kidney injury
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have